Refractory Chronic Lymphocytic Leukemia
Showing NaN - NaN of 6
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Duarte, California
- +2 more
Oct 7, 2022
Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)
Completed
- Anemia
- +13 more
- Entospletinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 29, 2021
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- Dasatinib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 15, 2021
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia
Completed
- Adult Acute Myeloid Leukemia in Remission
- +29 more
- Fludarabine Phosphate
- +5 more
-
Tucson, Arizona
- +9 more
Dec 18, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014